NTRA - Natera, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD

24.05

+0.07 (+0.29%)

At close: 4:00PM EDT

Stock chart is not supported by your current browser

Previous Close	23.98
Open	23.88
Bid	21.25 x 1100
Ask	24.05 x 3000
Day's Range	23.71 - 24.58
52 Week Range	8.60 - 29.62
Volume	764,179
Avg. Volume	773,335

Market Cap	1.466B
Beta	2.16
PE Ratio (TTM)	N/A
EPS (TTM)	-2.63
Earnings Date	Aug 6, 2018 - Aug 10, 2018
Forward Dividend & Yield	N/A (N/A)
Ex-Dividend Date	N/A
1y Target Est	24.00

Trade prices are not sourced from all markets

All

News

Press Releases

GuruFocus.com6 hours ago
Natera Inc (NTRA) CEO Matthew Rabinowitz Sold $5.1 million of Shares
CEO of Natera Inc (NASDAQ:NTRA) Matthew Rabinowitz sold 212,001 shares of NTRA on 09/21/2018 at an average price of $23.88 a share.
Simply Wall St.3 days ago
Have Investors Priced In Healthcare Growth For Natera Inc (NASDAQ:NTRA)?
Natera Inc (NASDAQ:NTRA), a US$1.45b small-cap, operates in the healthcare industry, which faces key trends such as rising demand fuelled by an aging population and the growing prevalence of chronicRead More...
GuruFocus.com8 days ago
Natera Inc (NTRA) CEO Matthew Rabinowitz Sold $10 million of Shares
CEO of Natera Inc (NASDAQ:NTRA) Matthew Rabinowitz sold 403,462 shares of NTRA on 09/13/2018 at an average price of $24.9 a share.
PR Newswire8 days ago
Natera Signs Agreement with Bristol-Myers Squibb to Investigate Signatera™ ctDNA Assay as a Potential Biomarker for Opdivo (nivolumab) in a Prospective Phase 2 Adjuvant Non-Small Cell Lung Cancer Clinical Trial
First Study Using ctDNA-based Minimal Residual Disease Assessment for Immunotherapy in the Adjuvant NSCLC Setting SAN CARLOS, Calif. , Sept. 13, 2018 /PRNewswire/ -- Natera, Inc. (NASDAQ: NTRA), a global ...
GlobeNewswire29 days ago
Detailed Research: Economic Perspectives on New Mountain Finance, Myers Industries, Pilgrim's Pride, Natera, Francesca's, and Synaptics — What Drives Growth in Today's Competitive Landscape
NEW YORK, Aug. 24, 2018-- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of New ...
American City Business Journalslast month
Why this developer — who's a tech CEO by day — sees San Carlos as fertile ground for new housing
The tech entrepreneur behind real estate startup Reali is also a developer with multiple projects in San Carlos' pipeline. Here's why he's drawn to this Peninsula city.
Thomson Reuters StreetEventslast month
Edited Transcript of NTRA earnings conference call or presentation 8-Aug-18 8:30pm GMT
Q2 2018 Natera Inc Earnings Call
PR Newswirelast month
GOLD PR | Social Media Named to the 2018 Inc. 5000 List of America's Fastest-Growing Private Companies
IRVINE, Calif. and NEW YORK, Aug. 17, 2018 /PRNewswire/ -- GOLD PR, a top marketing communications agency with offices in Orange County, Calif. and New York, announced that it was ranked #3172 on the 2018 Inc. 5000 list, which is the most prominent ranking of the nation's fastest-growing private companies. It is particularly exciting to be among the 12 percent of women-owned businesses," said Shari Gold, CEO of GOLD PR. Gold attributes her agency's significant growth over the past several years to consistently delivering performance and data-driven campaigns that drive results for clients.
PR Newswirelast month
Natera and Fox Chase Cancer Center to Collaborate on Kidney Cancer Study
SAN CARLOS, Calif. , Aug. 15, 2018 /PRNewswire/ -- Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA testing, has partnered with Fox Chase Cancer Center, one of the leading cancer centers ...
Zackslast month
Natera (NTRA) Reports Q2 Loss, Tops Revenue Estimates
Natera (NTRA) delivered earnings and revenue surprises of -5.77% and 3.49%, respectively, for the quarter ended June 2018. Do the numbers hold clues to what lies ahead for the stock?
Associated Presslast month
Natera: 2Q Earnings Snapshot
On a per-share basis, the San Carlos, California-based company said it had a loss of 62 cents. Losses, adjusted for non-recurring costs, came to 55 cents per share. The results did not meet Wall Street ...
PR Newswirelast month
Natera Reports Second Quarter 2018 Financial Results
SAN CARLOS, Calif. , Aug. 8, 2018 /PRNewswire/ -- Natera, Inc. (NASDAQ: NTRA), a leader in non-invasive genetic testing and the analysis of circulating cell-free DNA, today reported financial results ...
ACCESSWIRElast month
Natera, Inc. to Host Earnings Call
NEW YORK, NY / ACCESSWIRE / August 8, 2018 / Natera, Inc. (NASDAQ: NTRA ) will be discussing their earnings results in their Q2 Earnings Call to be held on August 8, 2018 at 4:30:00 PM Eastern Time. To ...
PR Newswirelast month
Natera Clinical Study Validates New Biomarker for Aneuploidy and Adverse Pregnancy Outcomes
SAN CARLOS, Calif., Aug. 7, 2018 /PRNewswire/ -- Natera, Inc. (NTRA), a leader in non-invasive genetic testing, today announced new study results demonstrating that fetal fraction, as measured by Panorama® non-invasive prenatal testing (NIPT), can be used as an independent biomarker to screen for certain chromosome abnormalities and adverse pregnancy outcomes. A recent review published in the New England Journal of Medicine1 highlighted the increased risk of false negative results from NIPT tests that fail to measure fetal fraction. Furthermore, additional studies have shown a higher rate of certain chromosomal abnormalities in pregnancies with low fetal fraction.2.3 In the new clinical study, published in Ultrasound in Obstetrics & Gynecology,4 Natera statisticians leveraged data from a subset of the over 1 million Panorama tests performed to date to devise an algorithm that flags cases where the fetal fraction is unexpectedly low, given the patient's weight and gestational age.
PR Newswire2 months ago
Study Shows Natera's Spectrum Preimplantation Genetic Testing for Aneuploidy Improves IVF Outcomes for All Women, Regardless of Maternal Age
The study, published in Fertility and Sterility, retrospectively analyzed pregnancy outcomes from more than 1,800 IVF cycles performed at two fertility centers using Spectrum, a single-nucleotide polymorphism (SNP)-based PGT-A technology.1 Spectrum screens all 24 chromosomes to provide comprehensive embryo aneuploidy results.
PR Newswire2 months ago
Natera Appoints Roy Baynes to Board of Directors, Adding Deep Oncology Experience
SAN CARLOS, Calif., July 31, 2018 /PRNewswire/ -- Natera (NTRA), a leader in non-invasive genetic testing, has appointed Roy Baynes, MB.BCh., M.Med., PhD, FCP, FACP, Chief Medical Officer at Merck, and Senior Vice President and Head of Global Clinical Development at Merck Research Laboratories, to its board of directors effective July 25, 2018. Dr. Baynes was previously Senior Vice President of Oncology, Inflammation, and Respiratory Therapeutics at Gilead Sciences, and also served as Vice President of Global Clinical Development and Therapeutic Area Head for Hematology/Oncology at Amgen.
Zacks2 months ago
Can The Uptrend Continue for Natera (NTRA)?
Natera, Inc. (NTRA) has been on the move lately as the stock has climbed in the past four weeks
Zacks2 months ago
Natera (NTRA) Catches Eye: Stock Jumps 6.3%
Natera (NTRA) shares rose more than 6% in the last trading session, amid huge volumes.
PR Newswire2 months ago
Natera Announces Pricing of Follow-On Offering
SAN CARLOS, Calif. , July 12, 2018 /PRNewswire/ -- Natera, Inc. (NASDAQ: NTRA), a leader in non-invasive genetic testing and the analysis of circulating cell-free DNA, today announced the pricing of its ...
PR Newswire2 months ago
Natera Launches Proposed Follow-On Offering
SAN CARLOS, Calif. , July 10, 2018 /PRNewswire/ -- Natera, Inc. (NASDAQ: NTRA), a leader in non-invasive genetic testing and the analysis of circulating cell-free DNA , today announced the launch of a ...
Motley Fool2 months ago
The 5 Best Healthcare Stocks of 2018 (So Far)
Here's what's pushing up the top-performing, non-pharmaceutical healthcare stocks.
Motley Fool3 months ago
Why Natera Inc. Is Rising Today
Shares jump in response to two bullish analyst notes. Here's what investors need to know.
PR Newswire3 months ago
Natera To Host Investor Conference Call to Discuss Strategic Roadmap in Organ Transplantation and Oncology
Commercializing Core Cell-free DNA Technology Beyond Reproductive Health SAN CARLOS, Calif. , June 21, 2018 /PRNewswire/ -- Natera, Inc. (NASDAQ: NTRA), a leader in genetic testing and cell-free DNA analysis, ...
PR Newswire3 months ago
Natera Develops Powerful Kidney Transplant Rejection Biomarker
Data to be Presented at The Transplantation Society International Congress in Madrid on July 3, 2018 SAN CARLOS, Calif. , June 21, 2018 /PRNewswire/ -- Natera, Inc. (NASDAQ: NTRA), a leader in cell-free ...